These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23579019)

  • 1. T1 mapping by CMR in cardiomyopathy: a noninvasive myocardial biopsy?
    Kramer CM; Chandrashekhar Y; Narula J
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):532-4. PubMed ID: 23579019
    [No Abstract]   [Full Text] [Related]  

  • 2. Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice.
    Thongsongsang R; Songsangjinda T; Tanapibunpon P; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Jun; 21(1):270. PubMed ID: 34082703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.
    Nam BD; Kim SM; Jung HN; Kim Y; Choe YH
    Int J Cardiovasc Imaging; 2018 Nov; 34(11):1769-1777. PubMed ID: 29846837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMR and amyloid cardiomyopathy: are we getting closer to the biology?
    Kwong RY; Jerosch-Herold M
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):166-8. PubMed ID: 24524743
    [No Abstract]   [Full Text] [Related]  

  • 5. The promise of myocardial fibrosis assessment by T1 mapping.
    Lima JA
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):485-7. PubMed ID: 23498677
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathology of cardiomyopathies.
    Becker AE
    Cardiovasc Clin; 1988; 19(1):9-31. PubMed ID: 3048689
    [No Abstract]   [Full Text] [Related]  

  • 7. Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement.
    Jackson E; Bellenger N; Seddon M; Harden S; Peebles C
    Clin Radiol; 2007 May; 62(5):395-403. PubMed ID: 17398263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning of native T1 mapping radiomics for classification of hypertrophic cardiomyopathy phenotypes.
    Antonopoulos AS; Boutsikou M; Simantiris S; Angelopoulos A; Lazaros G; Panagiotopoulos I; Oikonomou E; Kanoupaki M; Tousoulis D; Mohiaddin RH; Tsioufis K; Vlachopoulos C
    Sci Rep; 2021 Dec; 11(1):23596. PubMed ID: 34880319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy.
    Fattori R; Rocchi G; Celletti F; Bertaccini P; Rapezzi C; Gavelli G
    Am Heart J; 1998 Nov; 136(5):824-30. PubMed ID: 9812077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1 mapping in cardiac amyloidosis: can we get there from here?
    Ruberg FL
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):498-500. PubMed ID: 23498671
    [No Abstract]   [Full Text] [Related]  

  • 12. Morphological alterations in the heart muscle of cardiomyopathies.
    Olsen EG
    Cor Vasa; 1986; 28(4):241-7. PubMed ID: 3769484
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myocardial biopsy and its diagnostic possibilities in myocarditis and hypertrophic and dilated cardiomyopathies].
    Mravian SR; Frolov AN
    Kardiologiia; 1986 Mar; 26(3):110-5. PubMed ID: 3520079
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial Fibrosis Assessment Using T1 and ECV Mapping With Histologic Validation in Chronic Dilated Cardiomyopathy.
    Raafs AG; Adriaans BP; Henkens MTHM; Verdonschot JAJ; Ramaekers MJFG; Gommers S; Abdul Hamid MA; Schalla S; Knackstedt C; van Empel VPM; Brunner-la Rocca HP; Wildberger JE; Bekkers SCAM; Hazebroek MR
    JACC Cardiovasc Imaging; 2022 Oct; 15(10):1828-1830. PubMed ID: 36110030
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter by Ellims et al regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
    Ellims AH; Iles LM; Taylor AJ
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):e1. PubMed ID: 23512783
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genetic testing is superior to biopsy of the myocardium in cardiomyopathy - yes].
    Thanaraj A; Meder B
    Dtsch Med Wochenschr; 2013 Mar; 138(12):598. PubMed ID: 23483421
    [No Abstract]   [Full Text] [Related]  

  • 17. The cardiomyopathies: a review of terminology, pathology and pathogenesis.
    Davies MJ
    Histopathology; 1984 May; 8(3):363-93. PubMed ID: 6376322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyopathies.
    Edwards WD
    Hum Pathol; 1987 Jun; 18(6):625-35. PubMed ID: 3596582
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endomyocardial biopsy: clinical, diagnostic and morphological aspects].
    Bardosi A
    Dtsch Med Wochenschr; 1989 Oct; 114(43):1665-72. PubMed ID: 2680414
    [No Abstract]   [Full Text] [Related]  

  • 20. [Etiology and classification of cardiomyopathies].
    Sekiguchi M; Maezawa H
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):172-7. PubMed ID: 8492019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.